Review Articles Concerning Pulmonary Vascular Disease

Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension

Pramod Pharande, Arvind Sehgal, Samuel MenahemMonash Children’s Hospital, Monash Medical Centre and Monash University. University of Melbourne.Australia Journal of Cardiovascular Development and DiseaseJ Cardiovasc Dev Dis 2024; 11: DOI: 10.3390/jcdd11080233 AbstractBronchopulmonary dysplasia (BPD) remains the most common respiratory disorder of prematurity for infants born before 32 weeks of gestational age (GA). Early and prolonged exposure to […]

Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension Read More »

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery

Heidi M. Manour, Priya Muralidharan, Don Hayes Jr.University of Arizona. Ohio State University College of Medicine. United States Journal of Aerosol Medicine and Pulmonary Drug DeliveryJ Aerosol Med Pulm Drug Deliv 2024; 37: 202-218 DOI: 10.1089/jamp.2024.29117.mk AbstractAn increasing growth in nanotechnology is evident from the growing number of products approved in the past decade. Nanotechnology can

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery Read More »

The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?

Julie Wacker, Raphael Joye, Leon Genecand, Frederic Lador, Maurice BeghettiUniversity Hospitals of Geneva. Switzerland Expert Review of Clinical PharmacologyExpert Rev Clin Pharmacol 2024; DOI: 10.1080/17512433.2024.2396119 AbstractIntroduction: Pediatric pulmonary hypertension is a rare condition. Survival remains poor in the current management era. There is a lack of data regarding the medical management of pediatric pulmonary hypertension and most

The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met? Read More »

Absorbable metal stents for vascular use in pediatric cardiology: progress and outlook

Daniel I. McLennan, Jennifer R. Maldonado, Susan R. Foerster, Stephanie S. Handler, John F. LaDisa Jr., Todd M. Gudausky, Roger J. Guillory IIChildren’s Wisconsin and the Medical College of Wisconsin. Marquette University.United States Frontiers in Cardiovascular MedicineFront Cardiovas Med 2024; DOI: 10.3389/fcvm.2024.1410305 AbstractThe past five years have yielded impressive advancements in fully absorbable metal stent technology.

Absorbable metal stents for vascular use in pediatric cardiology: progress and outlook Read More »

An Interdisciplinary Consensus Approach to Pulmonary Hypertension in Developmental Lung Disorders

Nidhy P. Varghese, Eric D. Austin, Csaba Galambos, Mary P. Mullen, Delphine Yung, R. Paul Guillerman, Sara O. Vargas, Catherine M. Avitabile, Corey A. Chartan, Nahir Cortes-Santiago, Michaela Ibach, Emma O. Jackson, Jill Ann Jarrell, Roberta L. Keller, Usha S. Krishnan, Kalyani R. Patel, Jennifer Pogoriler, Elise C. Whalen, Kathryn Wikenheiser-Brokamp, Natalie M. Villafranco, Steven

An Interdisciplinary Consensus Approach to Pulmonary Hypertension in Developmental Lung Disorders Read More »

MR Lymphangiography: Congenital Lymphatic Flow Disorders

Seunghyun Lee, Saebeom Hur, Young Hun Choi, Jae-Yeon Hwang, Jung-Eun CheonSeoul National University Hospital and College of Medicine.Republic of Korea Investigative RadiologyInvest Radiol 2024; DOI: 10.1097/RLI.0000000000001112 AbstractCongenital lymphatic flow disorders collectively refer to a heterogeneous group of diseases that manifest as chylothorax, chylous ascites, intestinal lymphangiectasia, protein-losing enteropathy, and peripheral extremity or genital lymphedema, all in

MR Lymphangiography: Congenital Lymphatic Flow Disorders Read More »

Lymphatic Imaging and Intervention in Congenital Heart Disease

Christoph Bauer, Mario Scala, Jonathan J. Rome, Gerald Tulzer, Yoav DoriKepler University Hospital and Johannes Kepler University Linz. Children’s Hospital of Philadelphia.Austria and United States Journal of the Society for Cardiovascular Angiography and InterventionsJ Soc Cardiovasc Angiogr Interv 2024; 3:DOI: 10.1016/j.jscai.2023.101174 AbstractThe lymphatic system plays a central role in some of the most devastating complications associated

Lymphatic Imaging and Intervention in Congenital Heart Disease Read More »

Updates in Pediatric Sickle Cell Lung Disease

Michelle Gillespie, Olufunke Afolabi-Brown, Evans Machogu, Shaina Willen, Benjamin T. KoppOhio State University Wexner Medical Center and Nationwide Children’s Hospital.Children’ Hospital of Philadelphia. Riley Hospital for Children and Indiana University School of Medicine. University of California Davis Medical Center. Children’s Healthcare of Atlanta.United States Clinics in Chest MedicineClin Chest Med 2024; 45: 749-760DOI: 10.1016/j.ccm.2024.02.022 AbstractSickle cell

Updates in Pediatric Sickle Cell Lung Disease Read More »

Pulmonary Hypertension in Children

Rachel T. Sullivan, Eric D. AustinVanderbilt University Medical Center and Monroe Carrell Jr Children’s Hospital.United States Clinics in Chest MedicineClin Chest Med 2024; 45: 685-693DOI: 10.1016/j.ccm.2024.04.001 AbstractPulmonary hypertension (PH) may manifest at any age, including during childhood. While pediatric PH frequently associates with early life alterations that cause occult or overt pulmonary vascular disease, all forms

Pulmonary Hypertension in Children Read More »

Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases

L. Posado-Domínguez, A. J. Chamorro, E. Del Barco-Morillo, M. Martín-Galache, D. Bueno-Sacristán, E. Fonseca-Sánchez, A. Olivares-HernándezUniversity Hospital of Salamanca and University of Salamanca. Spain LifeLife 2024; 14:DOI: 10.3390/life14070865 AbstractThrombotic microangiopathy (TMA) is an anatomopathological lesion mediated by endothelial dysfunction and characterized by the creation of microthrombi in small vessels. In patients with cancer, it may be

Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases Read More »

Scroll to Top